MDHearing Volt vs Sontro Soundwave

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.

The Sontro Soundwave is a mid-priced OTC hearing aid that earns a B grade with a SoundScore of 3.0/5 in our lab testing. At $849, this behind-the-ear device uses disposable batteries and sits in the lower tier of OTC performance, ranking #61 of 65 devices in its category. The Soundwave's strongest attribute is own-voice comfort, scoring 3.6/5—a solid result that sits 1.09 points above the OTC category average. This makes it relatively comfortable for wearers who are sensitive to hearing their own voice sound unnatural or boomy. However, other performance areas present significant limitations. Speech clarity scores are below average in both quiet and noisy environments. Speech in quiet scores 2.7/5 (0.12 points below average), while speech in noise drops to 1.2/5 (0.28 points below average). Feedback handling is a notable weakness at 2.5/5, falling 2.04 points below the category average of 4.54/5. Perhaps most limiting is the music streaming score of 0.0/5, indicating this device does not support phone audio streaming—a feature many competitors in this price range offer. Consumers prioritizing own-voice comfort on a moderate budget may find the Soundwave acceptable, but those seeking strong speech clarity or streaming capability should consider alternatives. Several higher-performing OTC devices are available at similar or lower price points, including options like the Lexie Lumen or HearingAssist Control that deliver comparable or better overall sound quality.